Filter
3682
Filtered Results: 3682
Text search:
Therapie
Featured
Recommendations
397
New Publications
850
Language
Document type
No document type
1982
Studies & Reports
572
Guidelines
570
Manuals
177
Strategic & Response Plan
107
Fact sheets
98
Training Material
52
Brochures
37
Resource Platforms
30
Situation Updates
26
Infographics
22
Videos
4
Online Courses
3
Dashboards/Maps
1
App
1
Countries / Regions
Germany
192
India
168
Global
167
Kenya
92
South Africa
91
Western and Central Europe
76
Ethiopia
75
Uganda
63
Africa
60
Sierra Leone
58
Nigeria
54
Latin America and the Carribbean
45
Liberia
44
Nepal
43
Ghana
42
Tanzania
37
Malawi
36
Zambia
36
Rwanda
35
Bangladesh
35
Russia
31
Eastern Europe
29
Ukraine
27
Congo, Democratic Republic of
27
Myanmar / Burma
26
Philippines
24
Namibia
24
Zimbabwe
23
Indonesia
23
South Sudan
21
Lesotho
20
Mozambique
20
Brazil
20
Syria
19
Middle East and North Africa
19
Burkina Faso
18
West and Central Africa
18
South–East Asia Region
18
East and Southern Africa
16
Haiti
15
Cambodia
14
Senegal
13
Guinea
13
Asia
13
Eswatini/ Swaziland
13
Benin
11
Eastern Europe and Central Asia
11
USA
10
Pakistan
10
Yemen
9
Cameroon
8
Botswana
8
Venezuela
7
Vietnam
7
Afghanistan
6
Central African Republic
6
Mali
6
Tajikistan
5
Thailand
5
China
5
Western Pacific Region
5
Paraguay
5
Spain
5
Sudan
5
Iraq
5
North Macedonia
4
Switzerland
4
Colombia
4
North America
4
United Kingdom
4
Angola
4
Bhutan
4
Turkey
3
Albania
3
Laos
3
Jordan
3
Southern Africa
3
Romania
3
Georgia
3
Poland
3
Mexico
2
Serbia
2
Chile
2
Iran
2
Canada
2
Fiji
2
Singapore
2
Estonia
2
Uzbekistan
2
Burundi
2
Malaysia
2
Armenia
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
France
2
Mauritius
2
Bolivia
2
Argentina
2
Lebanon
2
Moldova
2
Sri Lanka
2
Madagascar
2
Timor Leste/ East Timor
1
El Salvador
1
Australia
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Niger
1
Peru
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Hungary
1
Ireland
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Belarus
1
Egypt
1
Palestine
1
Chad
1
Libya
1
Somalia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1199
Clinical Guidelines
362
Public Health
241
Women & Child Health
168
Key Resources
94
Capacity Building
46
Pharmacy & Technologies
38
Annual Report MEDBOX
1
Toolboxes
Mental Health
468
COVID-19
290
Refugee
224
HIV
209
AMR
204
NCDs
177
TB
171
Pharmacy
149
NTDs
105
Caregiver
104
Ebola
85
Disability
80
Rapid Response
77
Conflict
73
Global Health Education
55
Planetary Health
42
Natural Hazards
31
Health Financing Toolbox
20
Cholera
17
Social Ethics
17
Zika
14
Polio
10
Specific Hazards
9
South Sudan
1
Health Financing
1
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Schistosoma haematobium is a parasitic digenetic trematode responsible for schistosomiasis (also known as bilharzia). The disease is caused by penetration of the skin by the parasite, spread by intermediate host molluscs in stagnant waters, and can be treated by administration of praziquantel. Schis...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe, cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally kn...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
